Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02439645 · ClinicalTrials.gov registry record
A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 11
- Enrollment target
NCT02439645: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT02439645 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02439645 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This is a registry to examine genetic and clinical predictors of torsade de pointes events.
Primary Outcome
1. Definite TdP: At least 3 beats of polymorphic ventricular tachycardia (VT) or ventricular fibrillation (VF) on a 12-lead ECG or rhythm strip with documented QTc \> 450 ms in men or QTc \> 470 in women (excluding patients with conduction block or AF at baseline, see below) prior to arrhythmic event. 2. Probable TdP: At least 3 beats of polymorphic VT or VF on a 12-lead ECG or rhythm strip with QTc \> 450ms (men) or 470ms (women) after the event, or polymorphic VT or VF episode not meeting crit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-10 |
| Est. Completion | 2019-07-26 |
Why NCT02439645 stopped before completion
NCT02439645 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02439645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02439645 about?
NCT02439645 is a clinical study titled "A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes". This is a registry to examine genetic and clinical predictors of torsade de pointes events.
What is the current status of trial NCT02439645?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2013-10. Estimated completion is 2019-07-26.
Who is sponsoring clinical trial NCT02439645?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia